MRI-guided HDR brachytherapy or integrated VMAT boost for tumour-targeted dose escalation in localised prostate cancer: long-term results of the TARGET study
Publication date: January 2027 Source: Radiotherapy and Oncology, Volume 226 Author(s): Jerusha Padayachee, Noelia Sanmamed, Xiang Y. Ye, Zhihui Amy Liu, Jenny Lee, Alejandro Berlin, Tim Craig, Bernadeth Lao, Alexandra Rink, Andrew Bayley, Charles Catton, Warren Foltz, Andrew McPartlin, Sangeet Ghai, Rachel M. Glicksman, Mary Gospodarowicz, Padraig Warde, Cynthia Ménard, Peter Chung
MRI-guided HDR brachytherapy or integrated VMAT boost for tumour-targeted dose escalation in localised prostate cancer: long-term results of the TARGET study. // Radiotherapy & Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S016781402601296X?dgcid=rss_sd_all
MRI-guided HDR brachytherapy or integrated VMAT boost for tumour-targeted dose escalation in localised prostate cancer: long-term results of the TARGET study. Radiotherapy & Oncology. https://www.sciencedirect.com/science/article/pii/S016781402601296X?dgcid=rss_sd_all
“MRI-guided HDR brachytherapy or integrated VMAT boost for tumour-targeted dose escalation in localised prostate cancer: long-term results of the TARGET study.” Radiotherapy & Oncology.
@article{article63726,
title = {MRI-guided HDR brachytherapy or integrated VMAT boost for tumour-targeted dose escalation in localised prostate cancer: long-term results of the TARGET study},
journal = {Radiotherapy \& Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S016781402601296X?dgcid=rss_sd_all}
}